Combination of Acupuncture, Auricular Acupressure and Nicotine Replacement Therapy for Smoking Cessation
Launched by THE UNIVERSITY OF HONG KONG · Apr 14, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new approach to help people quit smoking. Researchers want to find out if combining acupuncture, auricular acupressure (a technique that applies pressure to specific points on the ear), and nicotine replacement therapy (like patches or gum) is more effective than using nicotine replacement therapy alone. They will look at how many people can successfully quit smoking after six months, if there are more side effects with the combined treatment, and if it helps reduce withdrawal symptoms (the discomfort people feel when they stop smoking).
To participate in this study, you need to be at least 18 years old, smoke at least 10 cigarettes a day, and have access to a smartphone for communication. You should also be able to read and write in Chinese. However, if you have certain health issues, like skin problems from diabetes, severe heart diseases, or are pregnant or breastfeeding, you won't be eligible to join. The trial will involve around 270 participants divided into three groups, so if you decide to take part, you'll be randomly assigned to one of these groups. This is a great opportunity for those looking to quit smoking and contribute to research that may help others in the future!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Individuals aged 18 or older.
- • 2. Individuals who consume at least 10 traditional cigarettes per day.
- • 3. Individuals with access to a smartphone for communication and internet use.
- • 4. Individuals who are able to read and write Chinese.
- Exclusion Criteria:
- • 1. Previous use of acupuncture for smoking cessation or any other condition.
- • 2. Skin problems related to diabetes.
- • 3. Hyperthyroidism.
- • 4. Hospitalized at Intensive Care Unit in the past 4 weeks.
- • 5. Severe cardiovascular diseases.
- • 6. Pregnancy.
- • 7. Breastfeeding.
- • 8. History of severe adverse reactions to acupuncture.
- • 9. Current use of blood-thinning medication or having a bleeding disorder.
- • 10. Current use of other smoking cessation services.
About The University Of Hong Kong
The University of Hong Kong (HKU) is a leading research institution dedicated to advancing medical knowledge and improving healthcare outcomes through innovative clinical trials. With a commitment to excellence in research and education, HKU collaborates with various stakeholders, including healthcare providers and industry partners, to conduct rigorous and ethically sound clinical studies. The university's diverse expertise and state-of-the-art facilities enable it to explore a wide range of therapeutic areas, contributing to the global pursuit of scientific advancement and the development of novel treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hong Kong, , Hong Kong
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported